Science and Medicine Group

Instrument Business Outlook Volume 33 - Issue 5 17 Jun 2024

Report details
6 Figures
21 Tables

Company Perspectives at ASMS 2024: The Present and the Future of MS
- Waters
- Thermo Fisher Scientific
- SCIEX
- Bruker
- Agilent Technologies
ASMS 2024: New Product Introductions
- timsTOF
- Orbitrap
- Quadrupole–Linear Ion Trap
- Triple Quad
- MALDI-TOF/TOF
- Quadrupole TOF
- DIA
- GC-MS
- GC-TOF
- Sample Prep
Executive Briefing
- Oxford Instruments to Buy Nanoidentation Company
- Repligen Names New CEO
- Confience Adds to LIMS Offerings
First Quarter Results: Bio-Rad Laboratories, Oxford Instruments, QIAGEN and Shim…
- Bio-Rad's ddPCR System Sales a Sales Hindrance
  - Parent Company
  - Life Science
  - Parent Company and Life Science Guidance
- Oxford Instruments Concludes Fiscal 2024 in Positive Territory
  - Overview
  - Orders
  - Divisions
  - Geography
  - Guidance
- QIAGEN Sales Led By Diagnostic Solutions Line
  - Product Lines
  - Regions
  - Guidance
- Shimadzu Finishes Fiscal 2024 With Growth
  - Q4
  - FYE
Market Profile: Nitrosamines in Pharmaceuticals
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: Financing Increases in 2023 and Positive Signs for 2024
- Academia and Government: US Government Obligations Rise
- Chemicals: Pressure on for M&A
Region Watch
- Netherlands: University Budget Cuts Proposed
- Germany: Chemical Industry Downturn
- China: R&D for Batteries
News
- Broad-Based Companies
  - Company Announcements
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Bioprocess Analysis
  - Company Announcements
  - Product Introduction
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Product Introductions
Bottom Line

Attachments

IBO 061724.pdf

Instrument Business Outlook Volume 33 - Issue 5

17 Jun 2024

Request Access

Table of Contents

Company Perspectives at ASMS 2024: The Present and the Future of MS
- Waters
- Thermo Fisher Scientific
- SCIEX
- Bruker
- Agilent Technologies
ASMS 2024: New Product Introductions
- timsTOF
- Orbitrap
- Quadrupole–Linear Ion Trap
- Triple Quad
- MALDI-TOF/TOF
- Quadrupole TOF
- DIA
- GC-MS
- GC-TOF
- Sample Prep
Executive Briefing
- Oxford Instruments to Buy Nanoidentation Company
- Repligen Names New CEO
- Confience Adds to LIMS Offerings
First Quarter Results: Bio-Rad Laboratories, Oxford Instruments, QIAGEN and Shimadzu
- Bio-Rad's ddPCR System Sales a Sales Hindrance
  - Parent Company
  - Life Science
  - Parent Company and Life Science Guidance
- Oxford Instruments Concludes Fiscal 2024 in Positive Territory
  - Overview
  - Orders
  - Divisions
  - Geography
  - Guidance
- QIAGEN Sales Led By Diagnostic Solutions Line
  - Product Lines
  - Regions
  - Guidance
- Shimadzu Finishes Fiscal 2024 With Growth
  - Q4
  - FYE
Market Profile: Nitrosamines in Pharmaceuticals
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Biopharma: Financing Increases in 2023 and Positive Signs for 2024
- Academia and Government: US Government Obligations Rise
- Chemicals: Pressure on for M&A
Region Watch
- Netherlands: University Budget Cuts Proposed
- Germany: Chemical Industry Downturn
- China: R&D for Batteries
News
- Broad-Based Companies
  - Company Announcements
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Bioprocess Analysis
  - Company Announcements
  - Product Introduction
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
- Life Science Consumables
  - Company Announcements
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Product Introductions
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Protein-Based Analysis
  - Product Introductions
Bottom Line